Ongoing Disclosure Notices - Directors
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Comvita Limited
Date this disclosure made:
21-May-26
Date of last disclosure:
11-Sept-24
Director or senior manager giving disclosure
Full name(s):
Bridget Coates
Name of listed issuer:
Comvita Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Chair
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares
Nature of the affected relevant interest(s):
Beneficial Interest
For that relevant interest-
Number held in class before acquisition or disposal:
45,000
Number held in class after acquisition or disposal:
82,802
Current registered holder(s):
Bridget Mary Coates - Custodial
Services Limited
Registered holder(s) once transfers are registered:
Bridget Mary Coates - Custodial
Services Limited
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:18-May-26
Nature of transaction:
Allotment of ordinary shares following
participation in Comvita’s
renounceable entitlement offer
announced on 15 April 2026.
Name of any other party or parties to the transaction (if known):N/A
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$0.65 per share
Number of financial products to which the transaction related: 37,802 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:21-May-26
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Comvita Limited
Date this disclosure made:
21-May-26
Date of last disclosure:
25-Jun-24
Director or senior manager giving disclosure
Full name(s):
Robert Major
Name of listed issuer:
Comvita Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares
Nature of the affected relevant interest(s):
Ms S A Parkinson & Mr R M Major –
Registered holder
For that relevant interest-
Number held in class before acquisition or disposal:
53,510
Number held in class after acquisition or disposal:
88,483
Current registered holder(s):
Robert Major
Registered holder(s) once transfers are registered:
N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:18-May-26
Nature of transaction:
Allotment of ordinary shares following
participation in Comvita’s
renounceable entitlement offer
announced on 15 April 2026.
Name of any other party or parties to the transaction (if known):N/A
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$0.65 per share
Number of financial products to which the transaction related: 34,973 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:21-May-26
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Comvita Limited
Date this disclosure made:
21-May-26
Date of last disclosure:
25-Jun-24
Director or senior manager giving disclosure
Full name(s):
Michael Sang
Name of listed issuer:
Comvita Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares
Nature of the affected relevant interest(s):
Beneficial Interest
For that relevant interest-
Number held in class before acquisition or disposal:
20,000
Number held in class after acquisition or disposal:
36,801
Current registered holder(s):
Michael Sang
Registered holder(s) once transfers are registered:
N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:18-May-26
Nature of transaction:
Allotment of ordinary shares following
participation in Comvita’s
renounceable entitlement offer
announced on 15 April 2026.
Name of any other party or parties to the transaction (if known):N/A
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
$0.65 per share
Number of financial products to which the transaction related: 16,801 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:21-May-26
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AGL — Accordant Group Limited: D&O Ongoing Notice - S Bennett2026-05-12
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Accordant Group Limited Date this disclosure made: 13-May-26 Date of last disclosu…”
- TAH — Third Age Health Services Limited: Amended Release - D&O Disclosure Bevan Walsh2026-05-14
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Third Age Health Services Limited Date this disclosure made: 15 May 2026 Date of l…”
- TAH — Third Age Health Services Limited: Ongoing Disclosure Notice - Bevan John Walsh2026-05-07
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Third Age Health Services Limited Date this disclosure made: 8 May 2026 Date of la…”